Technology for the treatment of stone disease has rapidly advanced, but a common nomenclature to communicate research and high-quality studies to assess treatment outcomes are lacking. Thus, guidelines are based… Click to show full abstract
Technology for the treatment of stone disease has rapidly advanced, but a common nomenclature to communicate research and high-quality studies to assess treatment outcomes are lacking. Thus, guidelines are based on low-grade evidence and cannot make definitive recommendations in many scenarios. To improve clinical practice and patient outcomes, the endourology community must unite to address these inadequacies.
               
Click one of the above tabs to view related content.